JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB199438

Anti-PGK1 antibody [EPR19057]

5

(2 Reviews)

|

(29 Publications)

Rabbit Recombinant Monoclonal PGK1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Mouse, Human, Rat samples. Cited in 29 publications.

View Alternative Names

PGKA, MIG10, OK/SW-cl.110, PGK1, Phosphoglycerate kinase 1, Cell migration-inducing gene 10 protein, Primer recognition protein 2, PRP 2

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)

Immunofluorescent analysis of 100% methanol-fixed Jurkat (human T cell leukemia cell line from peripheral blood) cells labeling PGK1 with ab199438 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining in Jurkat cells. The nuclear counterstain is DAPI (blue).

Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PGK1 antibody [EPR19057] (AB199438)

Immunofluorescent analysis of 100% methanol-fixed HeLa (human epithelial cell line from cervix adenocarcinoma) cells labeling PGK1 with ab199438 at 1/250 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/1000 dilution (green). Confocal image showing cytoplasmic and weak nuclear staining in HeLa cells. The nuclear counterstain is DAPI (blue).

Flow Cytometry (Intracellular) - Anti-PGK1 antibody [EPR19057] (AB199438)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-PGK1 antibody [EPR19057] (AB199438)

Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HeLa (Human epithelial cells from cervix adenocarcinoma) cells labeling PGK1 with ab199438 at 1/150 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (FITC) at 1/500 dilution was used as the secondary antibody.

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
  • WB

Supplier Data

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution

Lane 1:

Human fetal brain lysate at 10 µg

Lane 2:

Human fetal heart lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Exposure time: 1s

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
  • WB

Supplier Data

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution

Lane 1:

HeLa (Human epithelial cells from cervix adenocarcinoma) whole cell lysate at 20 µg

Lane 2:

HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 20 µg

Lane 3:

Jurkat (Human T cell leukemia cells from peripheral blood) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Exposure time: 1s

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
  • WB

Supplier Data

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/2000 dilution

Lane 1:

Mouse brain lysate at 10 µg

Lane 2:

Mouse heart lysate at 10 µg

Lane 3:

Mouse kidney lysate at 10 µg

Lane 4:

Rat brain lysate at 10 µg

Lane 5:

Rat heart lysate at 10 µg

Lane 6:

Rat kidney lysate at 10 µg

Lane 7:

C6 (Rat glial tumor cells) whole cell lysate

Lane 8:

RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate

Lane 9:

PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate

Lane 10:

NIH/3T3 (Mouse embryo fibroblast cells) whole cell lysate

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Exposure time: 1s

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
  • WB

Supplier Data

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)

Blocking and Diluting Buffer : 5% NFDM /TBST Lanes 3 and 4 Exposure : 60 seconds

Lanes 1 - 2:

Western blot - Anti-PGK1 antibody [EPR19057] (ab199438) at 1/1000 dilution

Lanes 3 - 4:

Western blot - Anti-PGK1 + PGK2 antibody [EPR14908] (<a href='/en-us/products/primary-antibodies/pgk1-pgk2-antibody-epr14908-ab186742'>ab186742</a>) at 1/5000 dilution

Lanes 1 and 3:

PGK1 Human Recombinant Protein at 20 µg

Lanes 2 and 4:

PGK2 Human Recombinant Protein at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 45 kDa

false

Exposure time: 5s

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)
  • WB

CiteAb

Western blot - Anti-PGK1 antibody [EPR19057] (AB199438)

PGK1 western blot using anti-PGK1 antibody [EPR19057] ab199438. Publication image and figure legend from Elkis, Y., Cohen, M., et al., 2017, Nat Commun, PubMed 29038547.

ab199438 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab199438 please see the product overview.

Development of the Fer/FerT kinase inhibitor-E260 by using a yeast-based HTS system. a Native Fer (pAES-Fer) and a mutated kinase inactive Fer (pAES-FerY715F) were expressed in yeast cells using the pAES expression vector. Protein lysates from transfected cells were subjected to WB analysis using anti-HA (for HA-tagged Fer), anti-Fer, anti-phosphotyrosine (p-tyr), and anti-actin antibodies. b Growth curve of yeast cells expressing either the empty pAES vector, native Fer, inactive Fer, and non-transformed yeast cells; n = 3,±SE. c Scheme of the HTS program. d The chemical structure the 0342 compound. e The chemical structure of the E260 compound. f Growth curve of yeast transformed with the different plasmids and treated with either DMSO, 2 µM E260, or 2 µM 0342. pAES-harboring cells treated with DMSO, mutant Fer treated with DMSO, native Fer-expressing cells treated with DMSO, native Fer-expressing cells treated with 0342, native Fer-expressing cells treated with E260. Untransformed yeast cells served as a negative control; n = 3, ±SE. g Histograms depicting the 600 nm OD readings of the yeast growth-curves (presented in f) after 40 h; n = 3, ±SE. h Protein lysates prepared from yeast expressing mutant Fer and treated with DMSO for 24 h (pAES-FerY715F), active Fer and treated with 2 µM E260 (pAES-Fer E260), active Fer and treated with DMSO (pAES-Fer DMSO), or harboring the pAES vector alone and treated with DMSO, were subjected to WB analysis using anti-Fer, anti-p-tyr, and anti-PGK antibodies. Arrow on the right depicts the MW of Fer. This image presents one experiment representative of three, which gave similar results

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR19057

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, ICC/IF, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "1/150", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PGK1 also known as phosphoglycerate kinase-1 is an enzyme involved in glycolysis with a mass of approximately 45 kDa. PGK1 catalyzes the reversible transfer of a phosphate group from 13-bisphosphoglycerate to ADP forming 3-phosphoglycerate and ATP. This enzyme is expressed ubiquitously across various tissues with significant roles in energy metabolism. In yeast it is referred to simply as phosphoglycerate kinase where its function in cellular respiration is widely studied.
Biological function summary

The PGK1 protein plays an essential role in energy production by participating in the glycolytic pathway. This enzyme functions independently and is not part of any complex. By converting 13-bisphosphoglycerate to 3-phosphoglycerate it supports cellular processes that require ATP. Such activity facilitates the high energy needs of cells ensuring proper cellular function and homeostasis.

Pathways

The enzyme PGK1 operates predominantly within the glycolytic and gluconeogenesis pathways. Throughout glycolysis it partners with enzymes like phosphofructokinase and pyruvate kinase facilitating the breakdown of glucose into pyruvate while generating ATP. In gluconeogenesis PGK1 aids in glucose formation which helps balance energy dynamics particularly in tissues like the liver and kidney.

PGK1 has associations with tumor growth and proliferation in various cancers. Its elevated expression is often found in tumors linking it to oncogenesis due to the increased demand for glycolytic activity. Additionally mutations in PGK1 can result in phosphoglycerate kinase deficiency a disorder affecting red blood cell metabolism. This links it to related proteins involved in managing metabolic pathways of energy production in affected tissues.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalyzes one of the two ATP producing reactions in the glycolytic pathway via the reversible conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate (PubMed : 30323285, PubMed : 7391028). In addition to its role as a glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha cofactor protein (primer recognition protein) (PubMed : 2324090). May play a role in sperm motility (PubMed : 26677959).
See full target information PGK1

Publications (29)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:4393 PubMed39910105

2025

Amyloids in bladder cancer hijack cancer-related proteins and are positive correlated to tumor stage.

Applications

Unspecified application

Species

Unspecified reactive species

Diego Alem,César X García-Laviña,Francisco Garagorry,Dardo Centurión,Joaquina Farias,Hany Pazos-Espinosa,María Noel Cuitiño-Mendiberry,Carolina Villadóniga,Susana Castro-Sowinski,Martín Fló,Federico Carrión,Brenda Iglesias,Kevin Madauss,Lucía Canclini

Cell death & disease 16:65 PubMed39900910

2025

LDHA-mediated glycolysis in stria vascularis endothelial cells regulates macrophages function through CX3CL1-CX3CR1 pathway in noise-induced oxidative stress.

Applications

Unspecified application

Species

Unspecified reactive species

Ying Yi,Min-Yu Wu,Kai-Tian Chen,An-Hai Chen,Lin-Qiu Li,Qin Xiong,Xian-Ren Wang,Wen-Bin Lei,Guan-Xia Xiong,Shu-Bin Fang

Signal transduction and targeted therapy 10:25 PubMed39837814

2025

Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8T and tumor cells.

Applications

Unspecified application

Species

Unspecified reactive species

Gui-Qi Zhu,Zheng Tang,Tian-Hao Chu,Biao Wang,Shi-Ping Chen,Chen-Yang Tao,Jia-Liang Cai,Rui Yang,Wei-Feng Qu,Yi Wang,Qian-Fu Zhao,Run Huang,Meng-Xin Tian,Yuan Fang,Jun Gao,Xiao-Ling Wu,Jian Zhou,Wei-Ren Liu,Zhi Dai,Ying-Hong Shi,Jia Fan

Clinical and translational medicine 15:e70118 PubMed39731281

2024

The antiarthritic effect of CBR-470-1 in hypoxic environment is to increase the level of NOD-like receptor family pyrin domain containing 3 ubiquitination by decreasing phosphoglycerate kinase 1 activity.

Applications

Unspecified application

Species

Unspecified reactive species

Ao Duan,Zemeng Ma,Xiaolong Shao,Zhencheng Xiong,Chaoyi Zhang,Wenzheng Liu,Guanglin Wang,Shouye Hu,Wei Lin

Hematological oncology 42:e3316 PubMed39526588

2024

Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect.

Applications

Unspecified application

Species

Unspecified reactive species

Jinrong Yang,Zixu Wang,Kun Wu,Bo Nie,Liyin Li,Jingyan Ruan,Qiang Zhou,Yun Zeng,Mingxia Shi

Science advances 10:eadn6016 PubMed39167658

2024

Phosphoglycerate kinase is a central leverage point in Parkinson's disease-driven neuronal metabolic deficits.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandros C Kokotos,Aldana M Antoniazzi,Santiago R Unda,Myung Soo Ko,Daehun Park,David Eliezer,Michael G Kaplitt,Pietro De Camilli,Timothy A Ryan

Drug development research 85:e22223 PubMed38879780

2024

Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking.

Applications

Unspecified application

Species

Unspecified reactive species

Qian Zhang,Dengfeng Chen

Cancer biology & therapy 25:2365449 PubMed38865161

2024

Sirtuin1 (sirt1) regulates the glycolysis pathway and decreases cisplatin chemotherapeutic sensitivity to esophageal squamous cell carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xuewen Yang,Shisen Li,Chunsheng Xu,Shushang Liu,Xiang Zhang,Bo Lian,Mengbin Li

Biomaterials research 28:0035 PubMed38840655

2024

Plant-Derived Exosomes as Novel Nanotherapeutics Contrive Glycolysis Reprogramming-Mediated Angiogenesis for Diabetic Ulcer Healing.

Applications

Unspecified application

Species

Unspecified reactive species

Minhong Tan,Yuda Liu,Yang Xu,Ge Yan,Nan Zhou,Haoran Chen,Zhihong Jiang,Lihua Peng

iScience 27:109735 PubMed38706843

2024

Glucose starvation causes ferroptosis-mediated lysosomal dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Kenji Miki,Mikako Yagi,Dongchon Kang,Yuya Kunisaki,Koji Yoshimoto,Takeshi Uchiumi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com